Neurologic Manifestations Associated with Parvovirus B19 Epidemic, Madrid, Spain, 2024

IF 6.6 2区医学 Q1 IMMUNOLOGY

Emerging Infectious Diseases Pub Date : 2025-07-14 DOI:10.3201/eid3108.250278

Cristina Veintimilla, Pilar Catalán, Agustín Estévez, Roberto Alonso, Maricela Valerio, Patricia Muñoz

引用次数: 0

Abstract

A reemergence of parvovirus B19 infections in Spain in early 2024 prompted a 10-year review of the virus at a tertiary center. We identified 8 case-patients with neurologic manifestations who had parvovirus B19 in cerebrospinal fluid. Early recognition and management of parvovirus B19–associated neurologic conditions will help yield favorable outcomes.

查看原文本刊更多论文

与细小病毒B19流行相关的神经表现，马德里，西班牙，2024

2024年初西班牙再次出现细小病毒B19感染，促使三级中心对该病毒进行了为期10年的审查。我们发现了8例脑脊液中有细小病毒B19的神经系统症状患者。早期识别和管理细小病毒b19相关的神经系统疾病将有助于产生良好的结果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Emerging Infectious Diseases 医学-传染病学

CiteScore

17.30

自引率

1.70%

发文量

505

审稿时长

1 months

期刊介绍： Emerging Infectious Diseases is a monthly open access journal published by the Centers for Disease Control and Prevention. The primary goal of this peer-reviewed journal is to advance the global recognition of both new and reemerging infectious diseases, while also enhancing our understanding of the underlying factors that contribute to disease emergence, prevention, and elimination. Targeted towards professionals in the field of infectious diseases and related sciences, the journal encourages diverse contributions from experts in academic research, industry, clinical practice, public health, as well as specialists in economics, social sciences, and other relevant disciplines. By fostering a collaborative approach, Emerging Infectious Diseases aims to facilitate interdisciplinary dialogue and address the multifaceted challenges posed by infectious diseases.